Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma: erratum

. 2017 Oct 5;2(9):e40. doi: 10.1097/IJ9.0000000000000040

PMCID: PMC5673129 PMID: 29177233

The following received and accepted dates were not included for this article published in the April 2017 issue.

This manuscript has been peer reviewed.

Footnotes

Published online 5 October 2017

1.Toomey P, Teta A, Patel K, et al. Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. IJS Oncol 2017;2(3):e15. DOI: 10.1097/IJ9.0000000000000015. [DOI] [PMC free article] [PubMed] [Google Scholar]